Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer. [electronic resource]
Producer: 20160510Description: 1521-31 p. digitalISSN:- 1538-8514
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- Animals
- Antineoplastic Agents, Phytogenic -- pharmacology
- Cell Line, Tumor
- Drug Resistance, Multiple -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Hyaluronic Acid -- chemistry
- Mice, Nude
- Microscopy, Confocal
- Microscopy, Electron, Transmission
- Nanoparticles -- chemistry
- Ovarian Neoplasms -- genetics
- Paclitaxel -- pharmacology
- Pyruvate Kinase -- genetics
- RNA, Small Interfering -- chemistry
- RNAi Therapeutics -- methods
- Reverse Transcriptase Polymerase Chain Reaction
- Tissue Distribution
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.